Arkolith/Insider Trading/PCVX/Form 4

Guggenhime Andrew

PRESIDENT AND CFOVaxcyte, Inc. (PCVX) · full profile →Form 4 · filed Jun 19, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$530K
Net Open-Market Flow
-$530K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 18, 2026Option exercise(M)10K$5.35$54K114K
Jun 18, 2026Sell(S)10K$53.00$530K104K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 18, 2026Option exercise(M)10K—$0237K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001230724-26-000010) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML